Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
782.1 USD | +2.55% | +0.87% | +34.11% |
04:49pm | UK weight-loss drug price rivalry intensifies with Pharmacy2U mark-down | RE |
02:43pm | Eli Lilly Ethics/Compliance Chief Alonzo Weems to Retire | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+34.11% | 69TCr | |
+31.37% | 59TCr | |
-2.79% | 36TCr | |
+20.41% | 33TCr | |
+5.47% | 29TCr | |
+14.83% | 24TCr | |
+9.93% | 21TCr | |
-6.95% | 20TCr | |
+11.01% | 17TCr | |
+0.09% | 16TCr |
- Stock Market
- Equities
- LLY Stock
- News Eli Lilly and Company
- Morgan Stanley Raises Price Target on Eli Lilly to $1,023 From $950 Amid 2024 Guidance Boost, Keeps Overweight Rating